Bio-Techne Corp (Germany) Buy Hold or Sell Recommendation

TE1 Stock   73.50  0.50  0.68%   
Assuming the 90 days trading horizon and your conservative risk appetite, our recommendation regarding Bio Techne Corp is 'Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Bio Techne Corp given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Bio Techne Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Bio-Techne Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more information on how to buy Bio-Techne Stock please use our How to Invest in Bio-Techne Corp guide.
Note, we conduct extensive research on individual companies such as Bio-Techne and provide practical buy, sell, or hold advice based on investors' constraints. Bio Techne Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Execute Bio-Techne Corp Buy or Sell Advice

The Bio-Techne recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bio Techne Corp. Macroaxis does not own or have any residual interests in Bio Techne Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bio-Techne Corp's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Bio-Techne CorpBuy Bio-Techne Corp
Sell

Market Performance

OKDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

Fairly ValuedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Barely shadows the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Bio Techne Corp has a Mean Deviation of 1.37, Semi Deviation of 1.75, Standard Deviation of 1.97, Variance of 3.86, Downside Variance of 6.02 and Semi Variance of 3.07
Macroaxis provides unbiased investment recommendation on Bio Techne Corp that should be used to complement current analysts and expert consensus on Bio Techne Corp. Our trade advice engine determines the company's potential to grow exclusively from the perspective of an investors' current risk tolerance and investing horizon. Use Bio Techne Corp market capitalization, as well as the relationship between the z score and net asset to ensure your buy or sell decision on Bio Techne Corp is adequate.

Bio-Techne Corp thematic classifications

IT Idea
IT
Information technology and IT services

Bio-Techne Corp Returns Distribution Density

The distribution of Bio-Techne Corp's historical returns is an attempt to chart the uncertainty of Bio-Techne Corp's future price movements. The chart of the probability distribution of Bio-Techne Corp daily returns describes the distribution of returns around its average expected value. We use Bio Techne Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bio-Techne Corp returns is essential to provide solid investment advice for Bio-Techne Corp.
Mean Return
0.17
Value At Risk
-3.47
Potential Upside
3.62
Standard Deviation
1.97
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bio-Techne Corp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Bio-Techne Corp Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bio-Techne Corp or IT sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bio-Techne Corp's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bio-Techne stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.16
β
Beta against Dow Jones0.17
σ
Overall volatility
2.02
Ir
Information ratio 0.07

Bio-Techne Corp Volatility Alert

Bio Techne Corp currently demonstrates below-average downside deviation. It has Information Ratio of 0.07 and Jensen Alpha of 0.16. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bio-Techne Corp's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bio-Techne Corp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Bio-Techne Corp Fundamentals Vs Peers

Comparing Bio-Techne Corp's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bio-Techne Corp's direct or indirect competition across all of the common fundamentals between Bio-Techne Corp and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bio-Techne Corp or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bio-Techne Corp's fundamental indicators could also be used in its relative valuation, which is a method of valuing Bio-Techne Corp by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Bio-Techne Corp to competition
FundamentalsBio-Techne CorpPeer Average
Current Valuation13.06 B16.62 B
Price To Book7.56 X9.51 X
Price To Sales12.34 X11.42 X
Revenue1.11 B9.43 B
EBITDA413.76 M3.9 B
Net Income272.05 M570.98 M
Total Debt243.41 M5.32 B
Cash Flow From Operations325.27 M971.22 M
Price To Earnings To Growth1.11 X4.89 X
Market Capitalization16.22 B19.03 B
Total Asset2.29 B29.47 B
Z Score39.68.72
Annual Yield0.01 %
Net Asset2.29 B

Bio-Techne Corp Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bio-Techne . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Bio-Techne Corp Buy or Sell Advice

When is the right time to buy or sell Bio Techne Corp? Buying financial instruments such as Bio-Techne Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Bio-Techne Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Construction Materials Thematic Idea Now

Construction Materials
Construction Materials Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Construction Materials theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Construction Materials Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Bio-Techne Stock Analysis

When running Bio-Techne Corp's price analysis, check to measure Bio-Techne Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Techne Corp is operating at the current time. Most of Bio-Techne Corp's value examination focuses on studying past and present price action to predict the probability of Bio-Techne Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio-Techne Corp's price. Additionally, you may evaluate how the addition of Bio-Techne Corp to your portfolios can decrease your overall portfolio volatility.